Inmune Bio, Inc.

INMBReported to SECin USCIK 0001711754Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at Inmune Bio, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Clark Ronnie Duane—Awardnothing paid100,000 sharesSep 23, 2026Clark Ronnie Duanenothing paidAward · Sep 23Award100,000Sep 23, 2026
SAPIRSTEIN JAMES—Awardnothing paid100,000 sharesSep 17, 2026SAPIRSTEIN JAMESnothing paidAward · Sep 17Award100,000Sep 17, 2026
Juda Scott—Option exercise$20,72114,801 sharesJul 7, 2026Juda Scott$20,721Exercise · Jul 7Option exercise14,801Jul 7, 2026
Lowdell Mark WilliamChief Scientific OfficerOption exercise$10,0957,211 sharesJul 7, 2026Lowdell Mark WilliamChief Scientific Officer$10,095Exercise · Jul 7Option exercise7,211Jul 7, 2026
Moss David JChief Executive OfficerOption exercise$12,6209,014 sharesJul 7, 2026Moss David JChief Executive Officer$12,620Exercise · Jul 7Option exercise9,014Jul 7, 2026